Compare MasTec Inc (MTZ) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MasTec Inc vs Summit Therapeutics Inc — how do they compare? MasTec Inc trades at $350.55 (market cap $26.60B), while Summit Therapeutics Inc trades at $14.57 (market cap $10.48B). The key difference: MasTec Inc is far larger — about 2.5× Summit Therapeutics Inc's market cap, and MasTec Inc is trading nearer its 52-week high, Summit Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| MTZ | SMMT | |
|---|---|---|
Market Cap | $26.60B | $10.48B |
Sector | Technology | Health |
52-Week High | $437.51 | $29.32 |
52-Week Low | $172.51 | $13.05 |
Enterprise Value | $29.34B | $9.90B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About MasTec Inc
MasTec, Inc. is a leading infrastructure construction company operating mainly in North America. The company's services cover a diverse range of end-markets, including communications (building fiber and wireless infrastructure), oil & gas, electric power (transmission, distribution, and clean energy), and industrial projects. MTZ provides critical engineering, procurement, and construction (EPC) services that support the expansion and maintenance of essential infrastructure across the continent.
Read more on MTZ →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
